Cameron Decker
Analyst-Equity presso RA Capital Management LP
Provenienza dei contatti di primo grado di Cameron Decker
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities.
20
| Private Company | Investment Managers | 20 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Cameron Decker tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Founder Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Analyst | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Masters Business Admin Doctorate Degree | |
| RESEARCH ALLIANCE CORP. II | Financial Conglomerates | Chief Executive Officer Founder | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Doctorate Degree | |
Forge Biologics, Inc.
 Forge Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Forge Biologics, Inc. operates as a gene therapy development engine, focused on enabling access to life changing gene therapies. The firm is a viral vector gene therapy manufacturing and development company with the dual platform of CDMO capabilities and the development of proprietary gene therapy products. The company was founded by Timothy J. Miller and Jaysson Eicholtz and is headquartered in Columbus, OH. | Miscellaneous Commercial Services | Director/Board Member | |
DTx Pharma, Inc.
 DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Indefinite Integral, Inc.
 Indefinite Integral, Inc. Financial ConglomeratesFinance Indefinite Integral, Inc. is a financial services company, which develops monetary contracts based on block chain. The company was founded by James Prestwich and is headquartered in San Francisco, CA. | Financial Conglomerates | Director of Finance/CFO | |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Cerebral Therapeutics, Inc.
 Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO. | Miscellaneous Commercial Services | Director/Board Member | |
| The Johns Hopkins University | College/University | Doctorate Degree | |
Kira Pharmaceuticals (US) LLC
 Kira Pharmaceuticals (US) LLC Pharmaceuticals: MajorHealth Technology Part of Kira Pharmaceuticals (Suzhou) Co., Ltd., Kira Pharmaceuticals (US) LLC develops transformative therapies for people with complement-mediated diseases. The company is based in Cambridge, MA. The company was founded by Gonghua Pan, Wenru Song. Frederick C. Beddingfield has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
| University of Connecticut | College/University | Doctorate Degree | |
Xenikos BV
 Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member | |
| University of Georgia | College/University | Undergraduate Degree | |
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Pharmaceuticals: Major | Director/Board Member | |
| MINERALYS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CANBRIDGE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
89Bio Ltd.
 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Part of 89bio, Inc., 89Bio Ltd. is an Israeli company that develops therapies and drugs for the treatment of patients living with nonalcoholic steatohepatitis. The company is based in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| CONNECT BIOPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Biotechnology | Director/Board Member | |
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Investment Managers | Director/Board Member | |
| DICE THER | Biotechnology | Director/Board Member | |
| TYRA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| Boston University | College/University | Undergraduate Degree | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree | |
| Texas A&M University | College/University | Undergraduate Degree | |
| University of Vermont | College/University | Undergraduate Degree | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
| University of Virginia | College/University | Undergraduate Degree | |
| Boston University School of Medicine | College/University | Graduate Degree | |
| Boston College | College/University | Undergraduate Degree | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
| University of Oregon | College/University | Undergraduate Degree | |
| International Rett Syndrome Foundation | Director/Board Member | ||
Indapta Therapeutics, Inc.
 Indapta Therapeutics, Inc. BiotechnologyHealth Technology Indapta Therapeutics, Inc. operates as a biotechnology company. It focuses on developing and commercializing a proprietary, first-in-class, off-the-shelf allogeneic cell therapy to treat multiple types of difficult-to-treat hematologic cancers and solid tumors. The company was founded by Guy DiPierro, Ronald A. Martell, Sungjin Kim and John Sunwoo in 2017 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 44 |
| Cina | 4 |
| Germania | 2 |
| Paesi Bassi | 2 |
| Israele | 2 |
Settori
| Health Technology | 23 |
| Consumer Services | 20 |
| Finance | 7 |
| Commercial Services | 3 |
Posizioni
| Director/Board Member | 83 |
| Independent Dir/Board Member | 31 |
| Analyst-Equity | 20 |
| Undergraduate Degree | 20 |
| Doctorate Degree | 13 |
Contatti più connessi
| Insiders | |
|---|---|
| Peter Kolchinsky | 32 |
| Andrew Levin | 22 |
| Derek DiRocco | 17 |
| Raj Shah | 16 |
| Matthew Hammond | 13 |
| Jake Simson | 11 |
| Zach Scheiner | 11 |
| Laura Stoppel | 9 |
| Brian Lewandowski | 5 |
| Ryan Berry | 5 |
| Drew Biedermann | 3 |
| David Migl | 3 |
| Ross Chikarmane | 3 |
| Katherine Terranova | 3 |
| Sonia Kartha | 2 |
- Borsa valori
- Insiders
- Cameron Decker
- Connessioni Società
